STABILIZATION OF SHORT TELOMERES AND TELOMERASE ACTIVITY ACCOMPANY IMMORTALIZATION OF EPSTEIN-BARR VIRUS-TRANSFORMED HUMAN B-LYMPHOCYTES

被引:355
|
作者
COUNTER, CM
BOTELHO, FM
WANG, P
HARLEY, CB
BACCHETTI, S
机构
[1] MCMASTER UNIV,DEPT PATHOL,MOLEC VIROL & IMMUNOL PROGRAMME,HAMILTON L8N 3Z5,ON,CANADA
[2] MCMASTER UNIV,DEPT BIOCHEM,HAMILTON L8N 3Z5,ON,CANADA
关键词
D O I
10.1128/JVI.68.5.3410-3414.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have measured telomere length and telomerase activity throughout the life span of clones of human B lymphocytes transformed by Epstein-Barr virus. Shortening of telomeres occurred at similar rates in all populations and persisted until chromosomes had little telomeric DNA remaining. At this stage, some of the clones entered a proliferative crisis and died. Only clones in which telomeres were stabilized, apparently by activation of telomerase, continued to proliferate indefinitely, i.e., became immortal. Since loss of telomeres impairs chromosome function, and may thus affect cell survival, we propose that telomerase activity is required for immortality. We have now detected this enzyme in a variety of immortal human cells transformed by different viruses, indicating that telomerase activation may be a common step in immortalization.
引用
收藏
页码:3410 / 3414
页数:5
相关论文
共 50 条
  • [1] EPSTEIN-BARR VIRUS-TRANSFORMED HUMAN B-LYMPHOCYTES PRODUCE NATURAL ANTIBODIES TO HISTONES
    GARZELLI, C
    INCAPRERA, M
    BAZZICHI, A
    MANUNTA, M
    ROGNINI, F
    FALCONE, G
    IMMUNOLOGY LETTERS, 1994, 39 (03) : 277 - 282
  • [2] Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity
    Kataoka, H
    Tahara, H
    Watanabe, T
    Sugawara, M
    Ide, T
    Goto, M
    Furuichi, Y
    Sugimoto, M
    DIFFERENTIATION, 1997, 62 (04) : 203 - 211
  • [3] CYTOKINE REGULATION OF THE EXPRESSION OF VIL-10 IN EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTES
    WANIDWORANUN, C
    JAMES, SP
    STROBER, W
    FASEB JOURNAL, 1992, 6 (05): : A1895 - A1895
  • [4] GLUCOCORTICOID RECEPTORS IN EPSTEIN-BARR VIRUS-TRANSFORMED HUMAN-LYMPHOCYTES
    TOMITA, M
    CHROUSOS, GP
    BRANDON, DD
    BENOR, S
    FOSTER, CM
    DEVOUGN, L
    TAYLOR, S
    LORIAUX, DL
    LIPSETT, MB
    HORMONE AND METABOLIC RESEARCH, 1985, 17 (12) : 674 - 678
  • [5] Increased cyclic AMP response to forskolin in Epstein-Barr virus-transformed human B-lymphocytes derived from schizophrenics
    Naoki Natsukari
    Henrietta Kulaga
    Ivory Baker
    Richard Jed Wyatt
    J. M. Masserano
    Psychopharmacology, 1997, 130 : 235 - 241
  • [7] Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes
    Klein, George
    Klein, Eva
    Kashuba, Elena
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (01) : 67 - 73
  • [8] IMMORTALIZATION OF HUMAN-LYMPHOCYTES BY EPSTEIN-BARR VIRUS
    MILLER, G
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1982, 55 (3-4): : 305 - 310
  • [9] INTERLEUKIN-2 PROMOTER ACTIVITY IN EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTES IS CONTROLLED BY NUCLEAR FACTOR-CHI-B
    MOUZAKI, A
    SERFLING, E
    ZUBLER, RH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) : 2177 - 2182
  • [10] EXPRESSION OF PLATELET GLYCOPROTEIN-IIB AND GLYCOPROTEIN-IIIA IN EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTES
    BENNETT, JS
    VILAIRE, G
    BEAVERSON, K
    PONCZ, M
    LOH, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1021 - 1021